World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
10982
World Ranking
3073
National Ranking
1439

Daniel H. Conrad publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniel H. Conrad sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 258 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Daniel H. Conrad D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel H. Conrad sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Daniel H. Conrad is affiliated with Virginia Commonwealth University in the United States. Their research primarily focuses on immunology and microbiology, with a significant portion of work also related to medicine.

The scientist's work spans multiple subfields, including:

  • Immunology
  • Molecular Biology
  • Epidemiology
  • Immunology and Allergy
  • Parasitology

Central themes in their research include:

  • Immune cells in cancer
  • Epigenetics and DNA Methylation
  • Immune Cell Function and Interaction
  • Immune Response and Inflammation
  • T-cell and B-cell Immunology
  • Vector-borne infectious diseases
  • Asthma and respiratory diseases

Recent publications authored or coauthored by Daniel H. Conrad include:

  • The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer (2020, BMC Immunology)
  • TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells (2020, Proceedings of the National Academy of Sciences)
  • Binding of Host Cell Surface Protein Disulfide Isomerase by Anaplasma phagocytophilum Asp14 Enables Pathogen Infection (2020, mBio)
  • Immunization against Anaplasma phagocytophilum Adhesin Binding Domains Confers Protection against Infection in the Mouse Model (2020, Infection and Immunity)
  • T cell receptor signaling defines the fate and pathway of ICOS internalization (2020, Biochemistry and Biophysics Reports)

Their work has been published in various journals, with frequent publications appearing in:

  • The Journal of Immunology
  • BMC Immunology
  • Proceedings of the National Academy of Sciences
  • mBio
  • Arthritis Research & Therapy

Daniel H. Conrad has collaborated extensively with several researchers including:

  • Rebecca Martin
  • Anuj Tharakan
  • Matthew Zellner
  • Joseph Lownik
  • Andrea Luker

Best Publications

  • ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins Such as Transforming Growth Factor α, L-Selectin, and Tumor Necrosis Factor α

    Sylvain M. Le Gall;Pierre Bobé;Karina Reiss;Keisuke Horiuchi

  • The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.

    Chunrong Yu;Mohamed Rahmani;Daniel Conrad;Mark Subler

  • Fc epsilon RII/CD23: the low affinity receptor for IgE.

    Daniel H. Conrad

  • ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23

    Gisela Weskamp;Jill W Ford;Jamie Sturgill;Steve Martin

  • A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects

    Jose Gomez-Arroyo;Sheinei J. Saleem;Shiro Mizuno;Aamer A. Syed

  • IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

    Jing Wang;Xiang Cheng;Xiang Cheng;Mei Xiang Xiang;Mervi Alanne-Kinnunen

  • Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE.

    Mangala Rao;W. T. Lee;D. H. Conrad

  • Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines

    S Z Ben-Sasson;G Le Gros;D H Conrad;F D Finkelman

  • Histone Deacetylase Inhibitors Promote STI571-mediated Apoptosis in STI571-sensitive and -resistant Bcr/Abl+ Human Myeloid Leukemia Cells

    Chunrong Yu;Mohamed Rahmani;Jorge Almenara;Mark Subler

  • Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells

    Susan A. Hudak;Sandra O. Gollnick;Daniel H. Conrad;Marilyn R. Kehry

  • IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production.

    S Z Ben-Sasson;G Le Gros;D H Conrad;F D Finkelman

  • ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo

    David R. Gibb;Mohey El Shikh;Dae Joong Kang;Warren J. Rowe

  • A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell–dependent murine model of allergic asthma

    Megan M. Price;Carole A. Oskeritzian;Yves T. Falanga;Kuzhuvelil B. Harikumar

  • Enhanced intestinal transepithelial antigen transport in allergic rats is mediated by IgE and CD23 (FcεRII)

    Ping-Chang Yang;M. Cecilia Berin;Linda C.H. Yu;Daniel H. Conrad

  • Enhanced transepithelial antigen transport in intestine of allergic mice is mediated by IgE/CD23 and regulated by interleukin-4

    Linda C.H. Yu;Ping-Chang Yang;M.Cecilia Berin;Vincenza Di Leo

  • IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo.

    Sarah Kennedy Norton;Brian Barnstein;Jennifer Brenzovich;Daniel P. Bailey

  • Binding Parameters of the Interaction Between Rat IgE and Rat Mast Cell Receptors

    Daniel H. Conrad;Hervé Bazin;Alec H. Sehon;Arnold Froese

  • Murine follicular dendritic cells and low affinity Fc receptors for IgE (Fc epsilon RII).

    K Maeda;G F Burton;D A Padgett;D H Conrad

  • Aberrant ORM (yeast)–like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice

    Clement Oyeniran;Jamie L. Sturgill;Nitai C. Hait;Wei-Ching Huang

  • Follicular dendritic cells and B cell costimulation.

    G F Burton;D H Conrad;A K Szakal;J G Tew

  • IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide.

    C M Snapper;F D Finkelman;D Stefany;D H Conrad

  • Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells.

    D H Conrad;S Z Ben-Sasson;G Le Gros;F D Finkelman

Frequent Co-Authors

John J. Ryan
John J. Ryan Virginia Commonwealth University
Fred D. Finkelman
Fred D. Finkelman University of Cincinnati
Sarah Spiegel
Sarah Spiegel Virginia Commonwealth University
Teruko Ishizaka
Teruko Ishizaka La Jolla Institute For Allergy & Immunology
Paul Dent
Paul Dent Virginia Commonwealth University
Steven Grant
Steven Grant Virginia Commonwealth University
Hannah J. Gould
Hannah J. Gould King's College London
Mohamed Rahmani
Mohamed Rahmani Khalifa University
Achsah D. Keegan
Achsah D. Keegan University of Maryland, Baltimore
Ping-Chang Yang
Ping-Chang Yang Shenzhen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career opportunities. Many professionals start with foundational nursing programs, such as the best online RN programs for non nurses, which provide a solid base for entering healthcare without prior nursing experience.

Once licensed as a registered nurse, accelerated pathways like the accelerated RN to NP programs offer a faster route to becoming a nurse practitioner. These programs are designed to help RNs advance their skill sets and take on specialized roles.

For those aiming to specialize further, pursuing an acute care nurse practitioner certification is a valuable step. This certification opens doors to working with critically ill patients and gaining expertise in acute medical conditions.

Moreover, finding accessible education options is crucial, and many students seek out accelerated nursing programs near me to start their careers promptly. These programs emphasize flexibility and speed, which align well with busy professionals or career changers interested in immunology-focused healthcare roles.

Best Scientists Citing Daniel H. Conrad

Trending Scientists

Recently Published Articles